CHISARI, CLARA GRAZIA
 Distribuzione geografica
Continente #
NA - Nord America 1.517
EU - Europa 1.085
AS - Asia 283
AF - Africa 278
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 3.171
Nazione #
US - Stati Uniti d'America 1.454
IE - Irlanda 339
IT - Italia 305
CI - Costa d'Avorio 207
CN - Cina 207
RU - Federazione Russa 164
UA - Ucraina 114
SN - Senegal 65
CA - Canada 63
DE - Germania 53
VN - Vietnam 30
FR - Francia 23
GB - Regno Unito 20
SE - Svezia 20
IN - India 16
CH - Svizzera 11
UZ - Uzbekistan 8
NL - Olanda 7
AE - Emirati Arabi Uniti 6
NG - Nigeria 5
PL - Polonia 5
FI - Finlandia 4
GR - Grecia 4
KR - Corea 4
TR - Turchia 4
AT - Austria 3
BG - Bulgaria 3
BR - Brasile 3
JP - Giappone 3
AU - Australia 2
BE - Belgio 2
CZ - Repubblica Ceca 2
EU - Europa 2
LB - Libano 2
AR - Argentina 1
HK - Hong Kong 1
HR - Croazia 1
ID - Indonesia 1
IM - Isola di Man 1
IR - Iran 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
NO - Norvegia 1
RO - Romania 1
Totale 3.171
Città #
Chandler 454
Dublin 331
Abidjan 207
Jacksonville 105
Ashburn 95
Catania 95
Cambridge 81
Lawrence 80
Andover 76
Dakar 65
Saint Petersburg 60
Nanjing 59
Des Moines 48
Toronto 47
Bremen 32
Dong Ket 26
Boardman 25
Wilmington 24
Nanchang 17
Shenyang 17
Beijing 14
Hebei 13
Rome 13
Redwood City 11
Kiev 10
Milan 10
Ottawa 10
San Francisco 10
San Mateo 10
Giarre 8
Houston 8
Pune 8
Seattle 8
Moscow 7
Tianjin 7
Abu Dhabi 6
Padova 6
Abuja 5
Changsha 5
Guangzhou 5
Jiaxing 5
Jinan 5
St Louis 5
Vicenza 5
Washington 5
Zhengzhou 5
Bari 4
Civitavecchia 4
Edinburgh 4
Hanoi 4
Irpin 4
Kunming 4
Palermo 4
Bengaluru 3
Boydton 3
Den Haag 3
Frankfurt Am Main 3
Istanbul 3
Lappeenranta 3
Mascalucia 3
Munich 3
Ningbo 3
Pozzallo 3
Samara 3
Shenzhen 3
Tortora 3
Woodbridge 3
Agrigento 2
Amsterdam 2
Arzano 2
Brussels 2
Casorezzo 2
Catenanuova 2
Chicago 2
Frankfurt am Main 2
Hangzhou 2
Lanuvio 2
Leawood 2
Liberty Lake 2
Licata 2
Markham 2
Menlo Park 2
Messina 2
Mountain View 2
Norwalk 2
Paris 2
Pioltello 2
Ragusa 2
San Giovanni la Punta 2
San Pietro in Casale 2
Seoul 2
Taizhou 2
Trecastagni 2
Aci Catena 1
Acireale 1
Ann Arbor 1
Ardabil 1
Augusta 1
Bangalore 1
Berlin 1
Totale 2.277
Nome #
The ocular ecosystem in the discoid lupus erythematosus 174
Aging eye microbiota in dry eye syndrome in patients treated with enterococcus faecium and saccharomyces boulardii 76
After the sweet comes the bitter. Time to halt the diabetic neuropathy epidemic 70
Amyotrophic lateral sclerosis: differential diagnosis with cervical myeloradiculopathy 64
Functional stress and microbiota eye in subjects with type 2 diabetes: a multifactorial approach 54
Microbiological Etiology of Chronic skin lesions in type 2 Diabetic Subjects 53
Lack of association between Toxocara canis and multiple sclerosis: A population-based case-control study 52
Prevalence and Incidence of Multiple Sclerosis in the City of Biancavilla 52
Cancer Risk and Multiple Sclerosis: Evidence From a Large Italian Cohort 51
Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: A randomized clinical trial 50
Functional Neurological disorders; those bizarre and painfull disconnections between brain and body 50
CSF neurotoxic metals/metalloids levels in amyotrophic lateral sclerosis patients: comparison between bulbar and spinal onset 50
AMNIOTIC MEMBRANE USE IN TYPE 2 DIABETES PATIENTS WITH CHRONIC ULCERS: MICROBIOLOGICAL EVALUATION AND THERAPEUTIC BENEFITS 48
Cancer risk assessment in multiple sclerosis patients in the Eastern Sicily 47
Lateral switch to IFN beta-1a 44 mcg may be effective as escalation switch to fingolimod in selected persons with relapsing remitting multiple sclerosis: a real-world setting experience 45
eMSQOL-29: Prospective validation of the abbreviated, electronic version of MSQOL-54 45
Retinal Thickness and Microvascular Pattern in Early Parkinson's Disease 45
Effectiveness and safety of Rituximab in demyelinating diseases spectrum: An Italian experience 44
Are oligoclonal bands associated to lower retinal layer thickness at the time of relapsing remitting multiple sclerosis diagnosis? Evidence from an exploratory study 44
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 44
The ocular surface in patients video display terminal (VDT) 44
Multiple Sclerosis in the Mount Etna region: possible role of volcanogenic trace elements 43
Migraine causes retinal and choroidal structural changes: evaluation with ocular coherence tomography 43
An update on the safety of treating relapsing-remitting multiple sclerosis 42
WII may improve physical abilities in multiple sclerosis: a randomized single blind study 41
Changes in Anti-JCV Antibody Status in a Large Population of Multiple Sclerosis Patients Treated with Natalizumab 41
The clinical value of Coop/Wonca charts in assessment of HRQoL in a large cohort of relapsing-remitting multiple sclerosis patients: Results of a multicenter study 40
Inpatient versus outpatient rehabilitation for multiple sclerosis patients: effects on disability and quality of life 40
Cardiovascular autonomic individual profile of relapsing-remitting multiple sclerosis patients and risk of extending cardiac monitoring after first dose fingolimod 40
An update on idiopathic intracranial hypertension in adults: a look at pathophysiology, diagnostic approach and management 40
Clinical-Instrumental patterns of neurodegeneration in Essential Tremor: A data-driven approach 40
Functional stress and alteration of the ocular surface in subjects video display terminal (VDT) 38
The effects of blood glucose regulation onn the microbiota ocular in Type II diabetic subjects 38
Multiple Sclerosis, COVID-19 and Vaccines: Making the Point 38
Valutazione dell’efficacia clinica-batteriologica dell’ofloxacina e della levofloxacina nelle congiuntiviti batteriche 37
Administration of subcutaneous interferon beta 1a in the evening: data from RELIEF study 37
Prevalence and incidence of cognitive impairment in multiple sclerosis: a population-based survey in Catania, Sicily 36
Microbiology synergism between tear substitutes and symbiotic treatment of patients with irritable bowel syndrome 36
Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up study 36
Treatment in worsening multiple sclerosis patients: new drugs are better than older ones? 35
Microbiological characteristics of the ocular surface in the patients with discoid lupus erythematosus. 35
A multicenter, observational, prospective study of self- and parent-reported quality of life in adolescent multiple sclerosis patients self-administering interferon-β1a using RebiSmartâ ¢â the FUTURE study 34
Risk factors for ocular surface disorders in patients with type 2 diabetes 34
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing–remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study) 34
Static postural control disturbances among the different multiple sclerosis phenotypes: A Neurocom Balance Manager®evaluation study 33
An update on the pharmacological management of pain in patients with multiple sclerosis 33
Correction to: Reliability of televisits for patients with mild relapsing-remitting multiple sclerosis in the COVID‑19 era 33
Etiology of chronic skin lesions in subjects with peripheral arterial disease 33
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 33
The Cost-effectiveness of Sativex®: The Italian Experience Based on " in Resistant Multiple Sclerosis Spasticity: Discontinuation Study in a Large Population of Italian Patients, SA.FE. Study" 32
Retinal Nerve Fiber Layer Thickness and Higher Relapse Frequency May Predict Poor Recovery after Optic Neuritis in MS Patients 32
Early-Onset Alcohol Dependence and Multiple Sclerosis: Diagnostic Challenges 32
Measurement Of Retinal Nerve Fibre Layer Thickness In Clinical Isolated Syndrome 31
The efficacy of natalizumab and fingolimod on cognition in relapsing-remitting multiple sclerosis patients 31
Clinical effectiveness of different natalizumab interval dosing schedules in a large Italian population of patients with multiple sclerosis 31
Pain Following the Use of Anesthesia Formulation Among Individuals Undergoing Cataract Surgery: A Randomized Controlled Trial 30
Pharmacokinetic drug evaluation of daclizumab for the treatment of relapsing-remitting multiple sclerosis 29
Toxoplasma gondii and multiple sclerosis: a population-based case–control study 28
Rituximab for the treatment of multiple sclerosis: a review 28
Esposizione ad elementi in tracce in aree ad alta incidenza di sclerosi multipla: un ruolo delle ceneri vulcaniche? 27
The mixture of bifidobacterium associated with fructooligosaccharides reduces the damage of the ocular surface 27
Pharmacoeconomics of synthetic therapies for multiple sclerosis 27
Pregnancy and the Postpartum Period in Women With Relapsing-Remitting Multiple Sclerosis Treated With Old and New Disease-Modifying Treatments: A Real-World Multicenter Experience 27
Retinal thickness and microvascular pathway in Idiopathic Rapid eye movement sleep behaviour disorder and Parkinson's disease 27
Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients 26
Gonadal Steroids and Sperm Quality in a Cohort of Relapsing Remitting Multiple Sclerosis: A Case-Control Study 26
Immunological Subsets Characterization in Newly Diagnosed Relapsing–Remitting Multiple Sclerosis 25
Patients with paediatric-onset multiple sclerosis are at higher risk of cognitive impairment in adulthood: An Italian collaborative study 24
Cognitive reserve is a determinant of social and occupational attainment in patients with pediatric and adult onset multiple sclerosis 24
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register 24
Effects of Nintendo Wii Fit® balance exercise program on physical abilities and quality of life in Multiple Sclerosis patients 23
Modificazioni della superficie oculare nei soggetti videoterminalisti 23
Evolution of the concept of vascular dementia 23
Natalizumab administration in multiple sclerosis patients during active SARS-CoV-2 infection: a case series 23
Pregnancy planning and management for women with multiple sclerosis: what has changed over the last 15 years? An Italian single-center experience 22
Palliative care in multiple sclerosis 21
Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter study 21
Objective evaluation of Nintendo Wii Fit Plus balance program training on postural stability in Multiple Sclerosis patients: a pilot study 20
Clinical bacteriological aspects of the Human Amniotic Membrane in the diabetic foot. A case report 19
Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study 19
Factors driving delayed time to multiple sclerosis diagnosis: Results from a population-based study 18
Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis Patients: Monocentric Case Series and Systematic Review of the Literature 17
Clinical and neurophysiological effects of fampridine in multiple sclerosis patients: a pilot study 17
Risk of Persistent Disability in Patients with Pediatric-Onset Multiple Sclerosis 17
Subclinical involvement of eye movements detected by video-based eye tracking in myasthenia gravis 14
Patients with multiple sclerosis choose a collaborative role in making treatment decision: results from the Italian multicenter SWITCH study 14
Reliability of televisits for patients with mild relapsing-remitting multiple sclerosis in the COVID-19 era 14
Cilostazol reduces dry eye symptoms and improve walking distance in patients with peripheral artery disease 14
A real-world evidence study of nabiximols in multiple sclerosis patients with resistant spasticity: Analysis in relation to the newly described 'spasticity-plus syndrome' 13
Abnormal Eye Movements due to Disease of the Extraocular Muscles and Their Innervation 13
Spasticity and Dystonia: A Brief Review 12
Identifying the Distinct Cognitive Phenotypes in Multiple Sclerosis 12
A dynamic interpretation of κFLC index for the diagnosis of multiple sclerosis: a change of perspective 11
Hopelessness in Multiple Sclerosis: Psychological and Organic Correlates 11
A model-based study of internuclear ophthalmoparesis and ocular-motor fatigue in multiple sclerosis 11
Pregnancy in multiple sclerosis women with relapses in the year before conception increases the risk of long-term disability worsening 11
Aging with multiple sclerosis: prevalence and profile of cognitive impairment 10
Retinal Thickness in Essential Tremor and Early Parkinson Disease: Exploring Diagnostic Insights 10
PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective study 10
Changes in John Cunningham Virus Index in Multiple Sclerosis Patients Treated with Different Disease-Modifying Therapies 9
Totale 3.305
Categoria #
all - tutte 12.247
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.247


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201941 0 0 0 0 0 0 0 0 0 6 14 21
2019/2020272 105 21 18 9 11 7 21 5 17 9 30 19
2020/2021335 15 21 26 11 102 9 28 8 21 19 34 41
2021/2022599 54 93 13 22 90 4 89 18 18 5 19 174
2022/20231.309 88 92 29 145 104 199 16 276 285 12 51 12
2023/2024541 34 161 42 33 27 165 11 57 8 3 0 0
Totale 3.365